Merck to split cancer, specialty drug businesses in leadership shakeup
Merck to split cancer, specialty drug businesses in leadership shakeup
Merck to split cancer, specialty drug businesses in leadership shakeup
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.